[Clinical evaluation of a new amebicide, Falmonox].
D000081:Acetamides / Q000627:therapeutic use; D000563:Amebicides / Q000627:therapeutic use*; D000588:Amines / Q000627:therapeutic use*; D001596:Benzylamines / Q000627:therapeutic use*; D004341:Drug Evaluation; D004404:Dysentery, Amebic / Q000188:drug therapy; D004749:Entamoebiasis / Q000188:drug therapy; D006801:Humans
D000081:Acetamides; D000563:Amebicides; D000588:Amines; D001596:Benzylamines; C017951:teclozan
Ocena kliniczna preparatu Falmonox w leczeniu pełzakowicy.